Nonsteroidal anti-inflammatory drugs (NSAIDs), cyclooxygenases, and the cell cycle: Their interactions in colon cancer

Advances in Experimental Medicine and Biology

Volumn 470, Issue , 2000, Pages 119-126

  Rigas, B ^a   Shiff, S J ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE;

APOPTOSIS; CANCER PREVENTION; CELL CYCLE; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; CONFERENCE PAPER; ENZYME REGULATION; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL CYCLE; COLONIC NEOPLASMS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0034468886     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (40)

1. Aspirin use and reduced risk of fatal colon cancer
2. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2
3. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer
4. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect
5. Upregulation of cyclooxygenase 2 gene expression in human colorectal adenomas and carcinomas
6. The mechanisms of action of nonsteroidal antiinflammatory drugs
7. Cyclins, CDKs, and cancer
8. 1 phase of the cell cycle by indomethacin
9. 1 phase of the cell cycle
10. The effect of sulindac on cell proliferation and the cell cycle distribution of human colon cancer cells
11. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells
12. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis
13. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
14. Principles of CDK regulation
15. 1 cyclins
16. G1 phase progression: Cycling on cue
17. The molecular basis for cell cycle delays following ionizing radiation: A review
18. Participation of p53 protein in the cellular response to DNA damage
19. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line
20. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents
21. Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis
22. p53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells
23. The retinoblastoma protein and cell cycle control
24. Sulindac for polyposis of the colon
25. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
26. Aberrant crypt foci of the colon as precursors of adenoma and cancer
27. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: Alterations in tumor suppressor and cell cycle-regulatory proteins
28. Sulindac sulfide alters the expression of cyclin proteins in HT-29 colon adenocarcinoma cells
29. Sulindac sulfide induces several subpopulations of colon cancer cells, defined by PCNA/Ki-67 and DNA strand breaks
30. Sulindac sulfide inhibits the proliferation of colon cancer cells - Diminished expression of the proliferation markers PCNA and Ki-67
31. Sulindac sulfide inhibits Ras signaling
32. Ras-like GTPases
33. Different expression patterns of cyclins A, D1, and E in human colorectal cancer
34. Concurrent amplification of cyclin E and cdk2 genes in colorectal carcinomas
35. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis
36. 1 delay in cells overexpressing prostaglandin endoperoxide synthase-2
37. Effects of nonsteroidal antiinflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
38. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: Enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines
39. Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction
40. p53 mutations in colorectal cancer